How advanced prostate cancer becomes resistant to androgen-deprivation therapy
Public release date: 1-Jun-2008 SEATTLE – For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating…
You must be logged in to post a comment.